Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better

Posted on October 16th, 2018 by in Pharma R&D

Genetic testing has become a big hit with consumers. Companies like Ancestry.com and 23andMe flood the airwaves with commercials about the joy of using DNA testing to find out about your heritage. But another reason genetic testing is attracting consumers is because it also can tell people about some of their genetic health risks. Continue reading “Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better” »

The nature of evidence in aging research

Posted on June 5th, 2017 by in Pharma R&D

It seems a while since there was focus on aging as a suitable target for pharmaceutical intervention. The days of Sirtuins and red wine may be long gone, but the scope of the opportunity to support healthy aging is becoming more relevant. It was therefore with some interest that I noticed several recent articles in FierceBiotech.

Continue reading “The nature of evidence in aging research” »

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 by in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Personalized vs. Precision Medicine

Posted on February 3rd, 2017 by in Pharma R&D

Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), Continue reading “Personalized vs. Precision Medicine” »

  1. 1
  2. 2